AVTX RSI Chart
Last 7 days
-8.6%
Last 30 days
-27.2%
Last 90 days
122.4%
Trailing 12 Months
-98.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 14.0M | 10.0M | 6.0M | 1.9M |
2022 | 6.1M | 3.8M | 17.4M | 18.1M |
2021 | 4.4M | 6.4M | 6.7M | 5.4M |
2020 | 6.9M | 6.9M | 5.8M | 6.7M |
2019 | 7.0M | 6.9M | 6.8M | 6.8M |
2018 | 32.2M | 36.5M | 15.6M | 7.0M |
2017 | 1.5M | 10.3M | 19.1M | 27.8M |
2016 | 0 | 0 | 0 | 1.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 27, 2023 | armistice capital, llc | sold | -486,888 | 0.5194 | -937,404 | - |
Jun 26, 2023 | caissa capital management ltd. | bought | -113,026 | 0.62 | -182,300 | - |
Jun 26, 2023 | armistice capital, llc | sold | -1,682,010 | 0.6125 | -2,746,140 | - |
Jun 26, 2023 | caissa capital management ltd. | bought | -917,153 | 0.6433 | -1,425,700 | - |
Jun 20, 2023 | caissa capital management ltd. | bought | 8,288 | 4.1444 | 2,000 | - |
Jun 16, 2023 | caissa capital management ltd. | bought | 11,714 | 3.9048 | 3,000 | - |
Jun 15, 2023 | caissa capital management ltd. | bought | 11,640 | 3.6837 | 3,160 | - |
Jun 14, 2023 | caissa capital management ltd. | bought | 20,874 | 3.479 | 6,000 | - |
Jun 13, 2023 | caissa capital management ltd. | bought | 33,439 | 3.8216 | 8,750 | - |
Jun 12, 2023 | caissa capital management ltd. | bought | 9,316 | 4.3352 | 2,149 | - |
Which funds bought or sold AVTX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | new | - | 1,014,590 | 1,014,590 | 0.11% |
May 15, 2024 | MORGAN STANLEY | reduced | -11.36 | 448 | 848 | -% |
May 15, 2024 | ADAR1 Capital Management, LLC | new | - | 130,500 | 130,500 | 0.03% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -7.13 | 19,599 | 35,670 | -% |
May 15, 2024 | Sio Capital Management, LLC | new | - | 220,784 | 220,784 | 0.07% |
May 15, 2024 | Royal Bank of Canada | added | 133 | 6,000 | 7,000 | -% |
May 14, 2024 | Affinity Asset Advisors, LLC | new | - | 217,500 | 217,500 | 0.03% |
May 14, 2024 | OLD POINT TRUST & FINANCIAL SERVICES N A | new | - | 22.00 | 22.00 | -% |
May 13, 2024 | UBS Group AG | added | 385,550 | 167,740 | 167,758 | -% |
May 13, 2024 | NATIXIS | reduced | -45.44 | 11,358 | 54,636 | -% |
Unveiling Avalo Therapeutics, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Avalo Therapeutics, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Avalo Therapeutics, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -100.0% | - | 571,000 | 236,000 | 643,000 | 769,500 | 896,000 | 14,949,000 | 1,033,000 | 1,173,000 | 219,500 | 1,350,000 | 3,355,000 | 473,000 | 1,496,500 | 1,111,000 | 1,338,000 | 2,754,000 | 580,808 | 2,201,232 | 1,391,942 | 2,576,369 |
Costs and Expenses | 298.2% | 32,767,000 | 8,229,000 | 3,986,000 | 7,793,000 | 9,267,000 | 9,750,500 | 10,854,000 | 12,861,000 | 22,026,000 | 18,182,000 | 17,813,000 | 20,484,000 | 31,053,000 | 17,835,000 | 14,388,000 | 13,153,000 | 34,167,000 | 6,303,643 | 5,062,795 | 3,940,011 | 7,581,311 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9,328,632 | 10,425,250 | 12,434,215 |
S&GA Expenses | -100.0% | - | 2,675,500 | 2,490,000 | 2,427,000 | 2,708,000 | 2,959,000 | 3,284,000 | 2,784,000 | 11,684,000 | 8,437,000 | 5,926,000 | 7,404,000 | 435,000 | 549,000 | 462,000 | 653,000 | 677,000 | 547,701 | 214,207 | 325,861 | 396,276 |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,401,189 |
EBITDA Margin | -380.5% | -73.54 | -15.31 | -5.11 | -2.19 | -1.90 | -2.13 | -2.64 | -17.42 | -13.74 | -13.97 | -11.38 | -11.28 | -18.01 | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | 486,000 | 735,000 | 704,000 | 675,000 | 599,000 | 826,000 | 831,000 | 789,000 | 796,000 | - | - | - | - | - | - | 262,500 | 262,500 | 262,500 | 262,500 |
Income Taxes | 177.8% | 7,000 | -9,000 | 8,000 | 7,000 | 8,000 | 8,500 | 5,000 | 5,000 | 9,000 | -11,500 | - | -200,000 | 11,000 | -141,000 | 3,000 | -500,000 | -2,200,000 | -30,504 | 121,640 | 100,000 | 100,000 |
Earnings Before Taxes | -1383.2% | -121,283,000 | -8,177,000 | -5,220,000 | -8,186,000 | -9,947,000 | -9,803,500 | 3,197,000 | -12,982,000 | -22,042,000 | - | -17,463,000 | -17,373,000 | -30,563,000 | - | -13,258,000 | -13,280,000 | -24,312,000 | - | -2,808,852 | -2,490,747 | -5,031,702 |
EBT Margin | -353.1% | -74.25 | -16.39 | -5.57 | -2.48 | -2.11 | -2.31 | -2.84 | -18.50 | -14.34 | -14.57 | -11.78 | -11.57 | -18.43 | - | - | - | - | - | - | - | - |
Net Income | -1384.9% | -121,290,000 | -8,168,000 | -5,228,000 | -8,193,000 | -9,955,000 | -9,812,000 | 3,192,000 | -12,987,000 | -22,051,000 | -19,196,000 | -17,395,000 | -17,105,000 | -30,680,000 | -15,643,000 | -13,459,000 | -13,281,000 | -21,117,000 | 1,621,054 | -4,016,454 | -6,223,099 | -7,454,048 |
Net Income Margin | -353.0% | -74.26 | -16.40 | -5.57 | -2.48 | -2.11 | -2.31 | -2.94 | -18.97 | -12.42 | -15.63 | -12.11 | -11.95 | -16.54 | - | - | - | - | - | - | - | - |
Free Cashflow | -124.2% | -6,200,000 | -2,766,000 | -6,814,000 | -11,048,000 | -10,052,000 | -3,940,000 | 5,687,000 | -12,526,000 | -16,067,000 | -17,110,000 | -16,371,000 | -19,187,000 | -18,337,000 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 489.4% | 124 | 21.00 | 29.00 | 24.00 | 36.00 | 33.00 | 37.00 | 32.00 | 62.00 | 80.00 | 95.00 | 64.00 | 63.00 | 44.00 | 59.00 | 69.00 | 44.00 | 36.00 | 57.00 | 60.00 | 75.00 |
Current Assets | 1224.8% | 111 | 8.00 | 13.00 | 8.00 | 19.00 | 16.00 | 19.00 | 15.00 | 44.00 | 62.00 | 77.00 | 47.00 | 46.00 | 26.00 | 41.00 | 50.00 | 25.00 | 18.00 | 13.00 | 14.00 | 27.00 |
Cash Equivalents | 1387.7% | 110 | 7.00 | 10.00 | 6.00 | 17.00 | 13.00 | 17.00 | 11.00 | 38.00 | 55.00 | 72.00 | 40.00 | 38.00 | 19.00 | 33.00 | 45.00 | 6.00 | 4.00 | 5.00 | 9.00 | 16.00 |
Inventory | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 |
Goodwill | 0% | 11.00 | 11.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 16.00 | 16.00 | 16.00 |
Liabilities | 1542.3% | 225 | 14.00 | 15.00 | 31.00 | 43.00 | 44.00 | 39.00 | 38.00 | 56.00 | 57.00 | 55.00 | 42.00 | 30.00 | 19.00 | 21.00 | 19.00 | 19.00 | 15.00 | 39.00 | 42.00 | 52.00 |
Current Liabilities | 4570.9% | 216 | 5.00 | 6.00 | 22.00 | 23.00 | 22.00 | 18.00 | 15.00 | 18.00 | 20.00 | 19.00 | 22.00 | 26.00 | 15.00 | 17.00 | 15.00 | 15.00 | 12.00 | 17.00 | 19.00 | 28.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 14.00 | 14.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 14.00 | 14.00 |
Shareholder's Equity | -1640.8% | -112 | 7.00 | 15.00 | - | -6.27 | -10.91 | - | - | 6.00 | 23.00 | 40.00 | 22.00 | 33.00 | 25.00 | 39.00 | 51.00 | 26.00 | 21.00 | 18.00 | 18.00 | 23.00 |
Retained Earnings | -36.2% | -456 | -335 | -326 | -321 | -313 | -303 | -294 | -297 | -284 | -262 | -243 | -225 | -208 | -177 | -162 | -148 | -135 | -114 | -115 | -111 | -105 |
Additional Paid-In Capital | 0.4% | 344 | 342 | 341 | 315 | 307 | 293 | 292 | 291 | 290 | 285 | 283 | 247 | 242 | 202 | 201 | 199 | 161 | 135 | 134 | 130 | 129 |
Shares Outstanding | 29.0% | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5.00 | - | - | - | 32.00 | - | - | - | 184 | - | - | - | 112 | - | - | - | 81.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -124.2% | -6,200 | -2,766 | -6,814 | -11,048 | -10,052 | -3,940 | 5,726 | -12,470 | -16,067 | -17,099 | -16,290 | -19,187 | -18,316 | -14,375 | -11,870 | -8,555 | -5,739 | -1,680 | -7,615 | -6,717 | -3,121 |
Share Based Compensation | -18.9% | 629 | 776 | 953 | 893 | 855 | 843 | 731 | 668 | 5,312 | 1,892 | 1,758 | 3,074 | 1,448 | 1,437 | 1,447 | 2,786 | 1,116 | 590 | 819 | 527 | 597 |
Cashflow From Investing | - | 356 | - | - | - | -133 | - | -39.00 | -56.00 | - | -11.00 | -81.00 | - | -21.00 | -391 | -63.00 | 12,837 | -1,251 | -180 | -5.08 | -90.96 | -165 |
Cashflow From Financing | 10861100.0% | 108,612 | 1.00 | 10,695 | 598 | 13,748 | 82.00 | - | -14,781 | - | 76.00 | 47,643 | 21,218 | 37,825 | 200 | 1.00 | 35,485 | 9,098 | 136 | 3,510 | 97.00 | 8,817 |
Buy Backs | - | - | - | - | 3,640 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |||
Revenues: | ||||
Total revenues, net | $ 0 | $ 475 | ||
Operating expenses: | ||||
Cost of product sales | (80) | 551 | ||
Research and development | 2,116 | 6,008 | ||
Acquired in-process research and development | 27,538 | 0 | ||
General and administrative | 3,193 | 2,708 | ||
Total operating expenses | 32,767 | 9,267 | ||
Total operating income (loss) | (32,767) | (8,792) | ||
Other expense: | ||||
Excess of warrant fair value over private placement proceeds | (79,276) | 0 | ||
Private placement transaction costs | (9,220) | 0 | ||
Change in fair value of derivative liability | (120) | (180) | ||
Interest income, net | 100 | (949) | ||
Other expense, net | 0 | (26) | ||
Total other expense, net | (88,516) | (1,155) | ||
Loss before taxes | (121,283) | (9,947) | ||
Income tax expense | 7 | 8 | ||
Net loss | (121,290) | (9,955) | ||
Comprehensive loss | $ (121,290) | $ (9,955) | ||
Net loss per share of common stock, basic (in dollars per share) | [1] | $ (141) | $ (204) | |
Net loss per share of common stock, diluted (in dollars per share) | [1] | $ (141) | $ (204) | |
Product revenue, net | ||||
Revenues: | ||||
Total revenues, net | $ 0 | $ 475 | ||
|
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 110,177 | $ 7,415 |
Other receivables | 35 | 136 |
Prepaid expenses and other current assets | 997 | 843 |
Restricted cash, current portion | 4 | 1 |
Total current assets | 111,213 | 8,395 |
Property and equipment, net | 1,882 | 1,965 |
Goodwill | 10,502 | 10,502 |
Restricted cash, net of current portion | 131 | 131 |
Total assets | 123,728 | 20,993 |
Current liabilities: | ||
Accounts payable | 916 | 446 |
Accrued expenses and other current liabilities | 7,383 | 4,172 |
Warrant liability | 194,901 | 0 |
Contingent consideration | 12,500 | 0 |
Total current liabilities | 215,700 | 4,618 |
Royalty obligation | 2,000 | 2,000 |
Deferred tax liability, net | 162 | 155 |
Derivative liability | 5,670 | 5,550 |
Other long-term liabilities | 1,281 | 1,366 |
Total liabilities | 224,813 | 13,689 |
Mezzanine equity: | ||
Temporary equity, values issued | 11,457 | 0 |
Stockholders’ (deficit) equity: | ||
Common stock—$0.001 par value; 200,000,000 shares authorized at March 31, 2024 and December 31, 2023; 1,034,130 and 801,746 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 1 | 1 |
Additional paid-in capital | 343,881 | 342,437 |
Accumulated deficit | (456,424) | (335,134) |
Total stockholders’ (deficit) equity | (112,542) | 7,304 |
Total liabilities, mezzanine equity and stockholders’ (deficit) equity | 123,728 | 20,993 |
Series C Preferred Stock | ||
Mezzanine equity: | ||
Temporary equity, values issued | 11,457 | 0 |
Series D Preferred Stock | ||
Mezzanine equity: | ||
Temporary equity, values issued | 0 | 0 |
Series E Preferred Stock | ||
Mezzanine equity: | ||
Temporary equity, values issued | $ 0 | $ 0 |